NEW YORK--(BUSINESS WIRE)--INNOVIVE Pharmaceuticals, Inc. (OTCBB:IVPH) today announced financial results for the three and six months ended June 30, 2007, and provided an update on recent corporate and clinical activities. Recent Corporate Highlights * Presented positive interim results from a Phase I clinical trial with INNO-406 in Gleevec®-resistant or intolerant chronic myelogenous leukemia (CML) at the American Society of Clinical Oncology Annual Meeting and the American Association of Cancer Research annual meeting
